Health Effects of Benzene Exposure among Children Following a Flaring Incident at the British Petroleum Refinery in Texas City

Human exposure to benzene is associated with multiple adverse health effects leading to hematological malignancies. The objective of this retrospective study was to evaluate the health consequences of benzene exposure in children following a flaring incident at the British petroleum (BP) refinery in...

Full description

Saved in:
Bibliographic Details
Published inPediatric hematology and oncology Vol. 31; no. 1; pp. 1 - 10
Main Authors D'Andrea, Mark A., Reddy, G. Kesava
Format Journal Article
LanguageEnglish
Published England Informa Healthcare 01.02.2014
Taylor & Francis
Subjects
Online AccessGet full text
ISSN0888-0018
1521-0669
1521-0669
DOI10.3109/08880018.2013.831511

Cover

Abstract Human exposure to benzene is associated with multiple adverse health effects leading to hematological malignancies. The objective of this retrospective study was to evaluate the health consequences of benzene exposure in children following a flaring incident at the British petroleum (BP) refinery in the Texas City, Texas. The study included children aged <17 years who had been exposed and unexposed to benzene. Using medical charts, clinical data including white blood cell (WBC) counts, platelets counts, hemoglobin, hematocrit, blood urea nitrogen (BUN), creatinine, alkaline phosphatase (ALP), aspartate amino transferase (AST), alanine amino transferase (ALT), and somatic symptom complaints by the children exposed to benzene were reviewed and analyzed. A total of 312 subjects (benzene exposed, n = 157 and unexposed, n = 155) were included. Hematologic analysis showed that WBC counts were significantly decreased in benzene-exposed children compared with the unexposed children (6.8 ± 2.1 versus 7.3 ± 1.7, P = .022). Conversely, platelet (X 103 per μL) counts were increased significantly in the benzene-exposed group compared with the unexposed group (278.4 ± 59.9 versus 261.6 ± 51.7, P = .005). Similarly, benzene-exposed children had significantly higher levels of ALP (183.7± 95.6 versus 165 ± 70.3 IU/L, P = .04), AST (23.6 ± 15.3 versus 20.5 ± 5.5 IU/L, P = .015), and ALT (19.2 ± 7.8 versus 16.9 ± 6.9 IU/L, P = .005) compared with the unexposed children. Together, the results of the study reveal that children exposed to benzene experienced significantly altered blood profiles, liver enzymes, and somatic symptoms indicating that children exposed to benzene are at a higher risk of developing hepatic or blood related disorders.
AbstractList Human exposure to benzene is associated with multiple adverse health effects leading to hematological malignancies. The objective of this retrospective study was to evaluate the health consequences of benzene exposure in children following a flaring incident at the British petroleum (BP) refinery in the Texas City, Texas. The study included children aged <17 years who had been exposed and unexposed to benzene. Using medical charts, clinical data including white blood cell (WBC) counts, platelets counts, hemoglobin, hematocrit, blood urea nitrogen (BUN), creatinine, alkaline phosphatase (ALP), aspartate amino transferase (AST), alanine amino transferase (ALT), and somatic symptom complaints by the children exposed to benzene were reviewed and analyzed. A total of 312 subjects (benzene exposed, n = 157 and unexposed, n = 155) were included. Hematologic analysis showed that WBC counts were significantly decreased in benzene-exposed children compared with the unexposed children (6.8 ± 2.1 versus 7.3 ± 1.7, P = .022). Conversely, platelet (X 103 per μL) counts were increased significantly in the benzene-exposed group compared with the unexposed group (278.4 ± 59.9 versus 261.6 ± 51.7, P = .005). Similarly, benzene-exposed children had significantly higher levels of ALP (183.7± 95.6 versus 165 ± 70.3 IU/L, P = .04), AST (23.6 ± 15.3 versus 20.5 ± 5.5 IU/L, P = .015), and ALT (19.2 ± 7.8 versus 16.9 ± 6.9 IU/L, P = .005) compared with the unexposed children. Together, the results of the study reveal that children exposed to benzene experienced significantly altered blood profiles, liver enzymes, and somatic symptoms indicating that children exposed to benzene are at a higher risk of developing hepatic or blood related disorders.
Human exposure to benzene is associated with multiple adverse health effects leading to hematological malignancies. The objective of this retrospective study was to evaluate the health consequences of benzene exposure in children following a flaring incident at the British petroleum (BP) refinery in the Texas City, Texas. The study included children aged <17 years who had been exposed and unexposed to benzene. Using medical charts, clinical data including white blood cell (WBC) counts, platelets counts, hemoglobin, hematocrit, blood urea nitrogen (BUN), creatinine, alkaline phosphatase (ALP), aspartate amino transferase (AST), alanine amino transferase (ALT), and somatic symptom complaints by the children exposed to benzene were reviewed and analyzed. A total of 312 subjects (benzene exposed, n = 157 and unexposed, n = 155) were included. Hematologic analysis showed that WBC counts were significantly decreased in benzene-exposed children compared with the unexposed children (6.8 ± 2.1 versus 7.3 ± 1.7, P = .022). Conversely, platelet (X 10 3 per μL) counts were increased significantly in the benzene-exposed group compared with the unexposed group (278.4 ± 59.9 versus 261.6 ± 51.7, P = .005). Similarly, benzene-exposed children had significantly higher levels of ALP (183.7± 95.6 versus 165 ± 70.3 IU/L, P = .04), AST (23.6 ± 15.3 versus 20.5 ± 5.5 IU/L, P = .015), and ALT (19.2 ± 7.8 versus 16.9 ± 6.9 IU/L, P = .005) compared with the unexposed children. Together, the results of the study reveal that children exposed to benzene experienced significantly altered blood profiles, liver enzymes, and somatic symptoms indicating that children exposed to benzene are at a higher risk of developing hepatic or blood related disorders.
Human exposure to benzene is associated with multiple adverse health effects leading to hematological malignancies. The objective of this retrospective study was to evaluate the health consequences of benzene exposure in children following a flaring incident at the British petroleum (BP) refinery in Texas City, Texas. The study included children aged <17 years who had been exposed and unexposed to benzene. Using medical charts, clinical data including white blood cell (WBC) counts, platelets counts, hemoglobin, hematocrit, blood urea nitrogen (BUN), creatinine, alkaline phosphatase (ALP), aspartate amino transferase (AST), alanine amino transferase (ALT), and somatic symptom complaints by the children exposed to benzene were reviewed and analyzed. A total of 312 subjects (benzene exposed, n = 157 and unexposed, n = 155) were included. Hematologic analysis showed that WBC counts were significantly decreased in benzene-exposed children compared with the unexposed children (6.8 ± 2.1 versus 7.3 ± 1.7, P = .022). Conversely, platelet (X 10(3) per μL) counts were increased significantly in the benzene-exposed group compared with the unexposed group (278.4 ± 59.9 versus 261.6 ± 51.7, P = .005). Similarly, benzene-exposed children had significantly higher levels of ALP (183.7± 95.6 versus 165 ± 70.3 IU/L, P = .04), AST (23.6 ± 15.3 versus 20.5 ± 5.5 IU/L, P = .015), and ALT (19.2 ± 7.8 versus 16.9 ± 6.9 IU/L, P = .005) compared with the unexposed children. Together, the results of the study reveal that children exposed to benzene experienced significantly altered blood profiles, liver enzymes, and somatic symptoms indicating that children exposed to benzene are at a higher risk of developing hepatic or blood related disorders.
Human exposure to benzene is associated with multiple adverse health effects leading to hematological malignancies. The objective of this retrospective study was to evaluate the health consequences of benzene exposure in children following a flaring incident at the British petroleum (BP) refinery in Texas City, Texas. The study included children aged <17 years who had been exposed and unexposed to benzene. Using medical charts, clinical data including white blood cell (WBC) counts, platelets counts, hemoglobin, hematocrit, blood urea nitrogen (BUN), creatinine, alkaline phosphatase (ALP), aspartate amino transferase (AST), alanine amino transferase (ALT), and somatic symptom complaints by the children exposed to benzene were reviewed and analyzed. A total of 312 subjects (benzene exposed, n = 157 and unexposed, n = 155) were included. Hematologic analysis showed that WBC counts were significantly decreased in benzene-exposed children compared with the unexposed children (6.8 ± 2.1 versus 7.3 ± 1.7, P = .022). Conversely, platelet (X 10(3) per μL) counts were increased significantly in the benzene-exposed group compared with the unexposed group (278.4 ± 59.9 versus 261.6 ± 51.7, P = .005). Similarly, benzene-exposed children had significantly higher levels of ALP (183.7± 95.6 versus 165 ± 70.3 IU/L, P = .04), AST (23.6 ± 15.3 versus 20.5 ± 5.5 IU/L, P = .015), and ALT (19.2 ± 7.8 versus 16.9 ± 6.9 IU/L, P = .005) compared with the unexposed children. Together, the results of the study reveal that children exposed to benzene experienced significantly altered blood profiles, liver enzymes, and somatic symptoms indicating that children exposed to benzene are at a higher risk of developing hepatic or blood related disorders.Human exposure to benzene is associated with multiple adverse health effects leading to hematological malignancies. The objective of this retrospective study was to evaluate the health consequences of benzene exposure in children following a flaring incident at the British petroleum (BP) refinery in Texas City, Texas. The study included children aged <17 years who had been exposed and unexposed to benzene. Using medical charts, clinical data including white blood cell (WBC) counts, platelets counts, hemoglobin, hematocrit, blood urea nitrogen (BUN), creatinine, alkaline phosphatase (ALP), aspartate amino transferase (AST), alanine amino transferase (ALT), and somatic symptom complaints by the children exposed to benzene were reviewed and analyzed. A total of 312 subjects (benzene exposed, n = 157 and unexposed, n = 155) were included. Hematologic analysis showed that WBC counts were significantly decreased in benzene-exposed children compared with the unexposed children (6.8 ± 2.1 versus 7.3 ± 1.7, P = .022). Conversely, platelet (X 10(3) per μL) counts were increased significantly in the benzene-exposed group compared with the unexposed group (278.4 ± 59.9 versus 261.6 ± 51.7, P = .005). Similarly, benzene-exposed children had significantly higher levels of ALP (183.7± 95.6 versus 165 ± 70.3 IU/L, P = .04), AST (23.6 ± 15.3 versus 20.5 ± 5.5 IU/L, P = .015), and ALT (19.2 ± 7.8 versus 16.9 ± 6.9 IU/L, P = .005) compared with the unexposed children. Together, the results of the study reveal that children exposed to benzene experienced significantly altered blood profiles, liver enzymes, and somatic symptoms indicating that children exposed to benzene are at a higher risk of developing hepatic or blood related disorders.
Author Reddy, G. Kesava
D'Andrea, Mark A.
Author_xml – sequence: 1
  givenname: Mark A.
  surname: D'Andrea
  fullname: D'Andrea, Mark A.
  email: kreddy_usa@yahoo.com, mmmeead@aol.com, mmmeead@aol.com, kreddy_usa@yahoo.com
  organization: University Cancer and Diagnostic Centers
– sequence: 2
  givenname: G. Kesava
  surname: Reddy
  fullname: Reddy, G. Kesava
  email: kreddy_usa@yahoo.com, mmmeead@aol.com, mmmeead@aol.com, kreddy_usa@yahoo.com
  organization: University Cancer and Diagnostic Centers
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24088183$$D View this record in MEDLINE/PubMed
BookMark eNqFkUFvEzEQhS1URNPCP0DIRy4b7F1vYnMAtVFCK1UCoXK2JutZ1pXXDrZXbTjw29klzQEO5TTW-HtPo_fOyIkPHgl5zdm84ky9Y1JKxricl4xXc1nxmvNnZMbrkhdssVAnZDYhxcSckrOU7hhjZbUsX5DTUoxfXFYz8usKweWOrtsWm5xoaOkl-p_oka4fdiENESn0wX-nq846E9HTTXAu3NtxBXTjIE6va99Ygz5TyDR3SC-jzTZ19AvmGBwOPf2KrfUY99R6eosPkOjK5v1L8rwFl_DV4zwn3zbr29VVcfP50_Xq4qZoBJe5MGZZiq0ol6o2RhhURqGChpcKapQSoCoFtqxmDLbVgm-NWLRcKQUGRkbI6py8PfjuYvgxYMq6t6lB58BjGJLmQomKLZmoR_TNIzpsezR6F20Pca-PmY3A-wPQxJBSxFY3NkO2wecI1mnO9FSQPhakp4L0oaBRLP4RH_3_I_t4kFnfhtjDfYjO6Ax7F2IbYUw_TeonHT785dD96b2BiPouDNGP6T99wm9Itbop
CitedBy_id crossref_primary_10_2139_ssrn_2516589
crossref_primary_10_1177_0009922815594358
crossref_primary_10_1007_s11356_022_18790_2
crossref_primary_10_1177_0009922816641463
crossref_primary_10_1289_EHP11750
crossref_primary_10_1017_dmp_2015_160
crossref_primary_10_7189_jogh_14_04045
crossref_primary_10_1016_j_envint_2018_08_056
crossref_primary_10_1186_1476_069X_13_82
crossref_primary_10_1177_07482337231212693
crossref_primary_10_3390_toxics10110678
crossref_primary_10_1016_j_scitotenv_2021_148135
crossref_primary_10_1080_10590501_2015_1002999
crossref_primary_10_1016_j_envres_2017_06_029
crossref_primary_10_1017_dmp_2017_59
crossref_primary_10_1186_s12944_023_01895_z
crossref_primary_10_2478_intox_2020_0009
crossref_primary_10_1186_1476_069X_13_115
crossref_primary_10_3390_ijerph20032275
crossref_primary_10_1177_2333794X18789275
crossref_primary_10_1097_JOM_0000000000000288
crossref_primary_10_29252_ismj_21_2_162
crossref_primary_10_4103_ijpvm_IJPVM_495_18
crossref_primary_10_3390_toxics10070351
crossref_primary_10_3390_atmos8060107
Cites_doi 10.1520/JFS14396J
10.1016/j.cbi.2010.01.002
10.1080/15287390802477338
10.1023/A:1019579430978
10.1016/j.mrrev.2005.04.003
10.1289/ehp.1002546
10.1289/ehp.11593
10.1146/annurev.publhealth.012809.103646
10.1093/toxsci/66.2.185
10.1016/S0016-5085(19)34763-8
10.1007/s10654-012-9727-1
10.1289/ehp.961041365
10.1002/ajim.20592
10.1111/1539-6924.00295
10.1016/S1383-5742(03)00053-X
10.1016/S0016-5085(62)80053-5
10.1080/00984100050166334
10.1177/0748233707080907
10.1186/1476-069X-9-31
10.1093/annhyg/10.4.317
10.1038/sj.leu.2401981
10.1520/JFS13444J
10.1080/00039890409605165
10.3109/02770903.2010.538106
10.1081/PFC-100104188
10.1289/ehp.1103921
10.1158/1055-9965.EPI-06-0262
ContentType Journal Article
Copyright 2014 Informa Healthcare USA, Inc. 2014
Copyright_xml – notice: 2014 Informa Healthcare USA, Inc. 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.3109/08880018.2013.831511
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1521-0669
EndPage 10
ExternalDocumentID 24088183
10_3109_08880018_2013_831511
831511
Genre Research Article
Journal Article
GeographicLocations Texas
GeographicLocations_xml – name: Texas
GroupedDBID ---
00X
03L
0BK
0R~
123
29O
36B
4.4
53G
AAJNR
AALUX
AAMIU
AAPUL
AAPXX
AAQRR
ABBKH
ABDBF
ABEIZ
ABLKL
ABOCM
ABPTK
ABUPF
ACENM
ACFUF
ACGEJ
ACGFS
ACLSK
ADCVX
ADFCX
ADRBQ
ADXPE
AECIN
AEGXH
AENEX
AEOZL
AEXWM
AEYQI
AFKVX
AFWLO
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJWEG
AKBVH
ALIIL
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AMDAE
BABNJ
BLEHA
BOHLJ
CCCUG
CS3
DKSSO
DU5
EAP
EBB
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
H13
HZ~
J.N
KRBQP
KSSTO
KWAYT
KYCEM
M44
M4Z
O9-
P2P
RNANH
RVRKI
SV3
TFDNU
TFL
TFW
TUS
UEQFS
V1S
~1N
ABJNI
ABLIJ
ABXYU
ACIEZ
ACUHS
ALYBC
TBQAZ
TDBHL
TERGH
TUROJ
.55
5VS
AAGDL
AALIY
AAORF
AAYXX
ABWCV
ABWVI
ABZEW
ACKZS
ACOPL
ACYZI
ADFOM
ADFZZ
ADYSH
AEIIZ
AFLEI
AFRVT
AJVHN
AMPGV
AWYRJ
BRMBE
CAG
CITATION
COF
CYYVM
CZDIS
DRXRE
DWTOO
JENTW
LJTGL
NUSFT
QQXMO
UDS
X7M
CGR
CUY
CVF
ECM
EIF
NPM
TASJS
7X8
ID FETCH-LOGICAL-c418t-dd724b42795dd4de9d9e9ac129a5e88aa324ef0500ab361bd46f1999ada129483
ISSN 0888-0018
1521-0669
IngestDate Fri Sep 05 09:37:33 EDT 2025
Mon Jul 21 06:04:21 EDT 2025
Tue Jul 01 00:44:54 EDT 2025
Thu Apr 24 23:03:20 EDT 2025
Wed Dec 25 09:05:28 EST 2024
Wed Jun 21 01:43:41 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c418t-dd724b42795dd4de9d9e9ac129a5e88aa324ef0500ab361bd46f1999ada129483
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 24088183
PQID 1494307045
PQPubID 23479
PageCount 10
ParticipantIDs crossref_citationtrail_10_3109_08880018_2013_831511
informaworld_taylorfrancis_310_3109_08880018_2013_831511
proquest_miscellaneous_1494307045
crossref_primary_10_3109_08880018_2013_831511
pubmed_primary_24088183
informahealthcare_journals_10_3109_08880018_2013_831511
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20140201
2/1/2014
2014-02-00
2014-Feb
PublicationDateYYYYMMDD 2014-02-01
PublicationDate_xml – month: 2
  year: 2014
  text: 20140201
  day: 1
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Pediatric hematology and oncology
PublicationTitleAlternate Pediatr Hematol Oncol
PublicationYear 2014
Publisher Informa Healthcare
Taylor & Francis
Publisher_xml – name: Informa Healthcare
– name: Taylor & Francis
References U.S. Environmental Protection Agency (CIT0022) 1998
CIT0034
Droz P (CIT0033) 1989; 46
Evans L (CIT0017) 2010
Docter HJ (CIT0037) 1967; 10
Reynolds P (CIT0024) 2002; 13
Weng HH (CIT0025) 2009; 72
Rothman N (CIT0028) 1996; 104
Barbera N (CIT0007) 1998; 43
CIT0016
Smith MT (CIT0002) 2010; 31
CIT0018
Sebesta DG (CIT0036) 1964; 47
Evans L. (CIT0015) 2010
CIT0019
Snyder R (CIT0004) 2000; 61
McHale CM (CIT0029) 2010; 119
Avis SP (CIT0006) 1993; 38
Goldman LR (CIT0011) 1995; 103
U.S. Environmental Protection Agency (CIT0021) 2003
Tunsaringkarn T (CIT0040) 2013; 1
CIT0001
CIT0023
Pyatt D (CIT0020) 2010; 184
Polin SG (CIT0035) 1962; 42
Neri M (CIT0012) 2006; 612
Ray MR (CIT0030) 2007; 23
Vinceti M (CIT0009) 2012; 27
Innerfield F. (CIT0032) 1960
Winek CL (CIT0008) 1971; 13
Kim S (CIT0014) 2006; 15
Whysner J (CIT0013) 2004; 566
Hattis D (CIT0027) 2003; 23
Ceresa C (CIT0031) 1960; 51
McDonald TA (CIT0038) 2001; 15
Inoue O (CIT0039) 1986; 43
Costantini AS (CIT0003) 2008; 51
Marchetti F (CIT0005) 2012; 120
CIT0026
Whitworth KW (CIT0010) 2008; 116
References_xml – volume: 43
  start-page: 1250
  issue: 6
  year: 1998
  ident: CIT0007
  publication-title: J Forensic Sci.
  doi: 10.1520/JFS14396J
– volume: 184
  start-page: 151
  issue: 1
  year: 2010
  ident: CIT0020
  publication-title: Chem Biol Interact.
  doi: 10.1016/j.cbi.2010.01.002
– volume: 72
  start-page: 83
  issue: 2
  year: 2009
  ident: CIT0025
  publication-title: J Toxicol Environ Health A
  doi: 10.1080/15287390802477338
– volume: 43
  start-page: 692
  issue: 10
  year: 1986
  ident: CIT0039
  publication-title: Br J Ind Med.
– volume-title: Enzymes in clinical chemistry
  year: 1960
  ident: CIT0032
– volume: 13
  start-page: 665
  issue: 7
  year: 2002
  ident: CIT0024
  publication-title: Cancer Causes Control
  doi: 10.1023/A:1019579430978
– volume: 612
  start-page: 14
  issue: 1
  year: 2006
  ident: CIT0012
  publication-title: Mutat Res.
  doi: 10.1016/j.mrrev.2005.04.003
– volume-title: Emissions Event (Incident No. 138052) Review on British Petrolium products, North America (Investigation No. 824714)
  year: 2010
  ident: CIT0017
– volume: 1
  start-page: 1
  year: 2013
  ident: CIT0040
  publication-title: Int J Environ Pollut Solutions
– volume: 119
  start-page: 628
  issue: 5
  year: 2010
  ident: CIT0029
  publication-title: Environ Health Perspect.
  doi: 10.1289/ehp.1002546
– volume: 46
  start-page: 547
  year: 1989
  ident: CIT0033
  publication-title: Brit J Ind Med.
– volume-title: BP's 40-Day Emissions Event
  year: 2010
  ident: CIT0015
– volume: 116
  start-page: 1576
  issue: 11
  year: 2008
  ident: CIT0010
  publication-title: Environ Health Perspect.
  doi: 10.1289/ehp.11593
– volume: 31
  start-page: 133
  year: 2010
  ident: CIT0002
  publication-title: Annu Rev Public Health
  doi: 10.1146/annurev.publhealth.012809.103646
– ident: CIT0026
  doi: 10.1093/toxsci/66.2.185
– volume: 47
  start-page: 166
  year: 1964
  ident: CIT0036
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(19)34763-8
– volume: 27
  start-page: 781
  issue: 10
  year: 2012
  ident: CIT0009
  publication-title: Eur J Epidemiol.
  doi: 10.1007/s10654-012-9727-1
– volume: 13
  start-page: 259
  issue: 5
  year: 1971
  ident: CIT0008
  publication-title: J Occup Med.
– volume: 104
  start-page: 1365
  issue: 6
  year: 1996
  ident: CIT0028
  publication-title: Environ Health Perspect.
  doi: 10.1289/ehp.961041365
– volume-title: Carcinogenic Effects of Benzene: An Update
  year: 1998
  ident: CIT0022
– volume: 51
  start-page: 803
  issue: 11
  year: 2008
  ident: CIT0003
  publication-title: Am J Ind Med.
  doi: 10.1002/ajim.20592
– volume: 51
  start-page: 3544
  year: 1960
  ident: CIT0031
  publication-title: Minerva Med.
– ident: CIT0016
– volume: 23
  start-page: 117
  issue: 1
  year: 2003
  ident: CIT0027
  publication-title: Risk Anal.
  doi: 10.1111/1539-6924.00295
– volume: 566
  start-page: 99
  issue: 2
  year: 2004
  ident: CIT0013
  publication-title: Mutat Res.
  doi: 10.1016/S1383-5742(03)00053-X
– ident: CIT0018
– volume: 42
  start-page: 431
  year: 1962
  ident: CIT0035
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(62)80053-5
– volume: 61
  start-page: 339
  issue: 5
  year: 2000
  ident: CIT0004
  publication-title: J Toxicol Environ Health A
  doi: 10.1080/00984100050166334
– volume: 23
  start-page: 167
  issue: 3
  year: 2007
  ident: CIT0030
  publication-title: Toxicol Ind Health
  doi: 10.1177/0748233707080907
– ident: CIT0001
  doi: 10.1186/1476-069X-9-31
– volume: 10
  start-page: 317
  issue: 4
  year: 1967
  ident: CIT0037
  publication-title: Ann Occup Hyg.
  doi: 10.1093/annhyg/10.4.317
– volume: 15
  start-page: 10
  issue: 1
  year: 2001
  ident: CIT0038
  publication-title: Leukemia.
  doi: 10.1038/sj.leu.2401981
– volume: 38
  start-page: 599
  issue: 3
  year: 1993
  ident: CIT0006
  publication-title: J Forensic Sci.
  doi: 10.1520/JFS13444J
– volume: 103
  start-page: 13
  issue: 6
  year: 1995
  ident: CIT0011
  publication-title: Environ Health Perspect.
– ident: CIT0023
  doi: 10.1080/00039890409605165
– ident: CIT0019
  doi: 10.3109/02770903.2010.538106
– ident: CIT0034
  doi: 10.1081/PFC-100104188
– volume-title: Integrated Risk Information System (IRIS): Benzene
  year: 2003
  ident: CIT0021
– volume: 120
  start-page: 229
  issue: 2
  year: 2012
  ident: CIT0005
  publication-title: Environ Health Perspect.
  doi: 10.1289/ehp.1103921
– volume: 15
  start-page: 2246
  issue: 11
  year: 2006
  ident: CIT0014
  publication-title: Cancer Epidemiol Biomarkers Prev.
  doi: 10.1158/1055-9965.EPI-06-0262
SSID ssj0002372
Score 2.1200871
Snippet Human exposure to benzene is associated with multiple adverse health effects leading to hematological malignancies. The objective of this retrospective study...
SourceID proquest
pubmed
crossref
informaworld
informahealthcare
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1
SubjectTerms Accidents, Occupational
Adolescent
Air Pollutants - toxicity
Benzene - toxicity
benzene poisoning
Blood Cell Count
blood disorders
chemical exposure
Chemical Industry
Child
Creatinine - blood
Digestive System Diseases - blood
Digestive System Diseases - chemically induced
Digestive System Diseases - epidemiology
Environmental Exposure
Exanthema - chemically induced
Exanthema - epidemiology
Female
health impact
hematological toxicity
Hemoglobins - analysis
hepatotoxicity
Humans
Kidney - drug effects
Liver - drug effects
Liver Function Tests
Male
Nervous System Diseases - chemically induced
Nervous System Diseases - epidemiology
Petroleum
petroleum refinery
Phenol - urine
Respiratory Tract Diseases - chemically induced
Respiratory Tract Diseases - epidemiology
Retrospective Studies
Sex Factors
Texas
urinary metabolites of benzene
Title Health Effects of Benzene Exposure among Children Following a Flaring Incident at the British Petroleum Refinery in Texas City
URI https://www.tandfonline.com/doi/abs/10.3109/08880018.2013.831511
https://www.ncbi.nlm.nih.gov/pubmed/24088183
https://www.proquest.com/docview/1494307045
Volume 31
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZgKyEuqLy3PGQkOK1SNrETO8c-KBWoHNBW6i1y_FCR2qRiswX1wG9n_Ep2YUuBS7RK7ETZ7_N47Mx8g9BrlaqUpUYmmclVQkstElEKnqiU1JwLWRq3lX30qTg8ph9O8pMhVtVll3T1trxam1fyP6jCOcDVZsn-A7L9TeEE_AZ84QgIw_GvMA45REsxGbVursB6WeH-du6-DbhiQn3KtgHY228uMXFiYFHrM1qkrSwa8xonUefIFttqz_TiHDAwNkfQpQjO9Hcxn-x96Va-B_cVPyZOBHYQdmobubJxv_8mYy6IUsRMoWE39bNW3uS_n3zUc3EplrckUhqjmO2MEsxoZuOpfBGWaGeDtV_mkzea6TpTTrwSKhhBbgsH2iA8ss0JOCgrzQGQi3MHr9VqA--DDBNbH24YL91GGxkDF2uENnZ293cP-ik7IyzzeZX2sW_XPdSqRofbrLgwm0Hg9rQP1_tF9Pb6pYtzYWab6F5Ye-AdT6T76JZuHqA7RyG64iH64fmEA59wa3DgE458wo5POPIJ93zCAgc-4cgnLDoMfMKBT7jnE458gqbY8QlbPj1CxwfvZnuHSajPkUia8i5RimW0phkrc6Wo0qUqdSkkeJAi1zDQBTjr2kzz6VTUpEhrRQtjVS-EEtCGcvIYjZq20U8RJkoWGTeSaF7QGnpLVjCmVGFMysHJGiMS__JKBvF6W0PlrIJFrMWsiphVFrPKYzZGSd_rwou33NCe_YZmFcb7_IaefBnzqnPbbcbXxrHd_tT1VeRHBabdfq8TjW4X8EBqayMwWHSN0RNPnP41Ihe3rr3yDN0dxuZzNOq-LvQLcKC7-mWg_086xsF2
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Health+effects+of+benzene+exposure+among+children+following+a+flaring+incident+at+the+British+Petroleum+Refinery+in+Texas+City&rft.jtitle=Pediatric+hematology+and+oncology&rft.au=D%27Andrea%2C+Mark+A&rft.au=Reddy%2C+G+Kesava&rft.date=2014-02-01&rft.eissn=1521-0669&rft.volume=31&rft.issue=1&rft.spage=1&rft_id=info:doi/10.3109%2F08880018.2013.831511&rft_id=info%3Apmid%2F24088183&rft.externalDocID=24088183
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0888-0018&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0888-0018&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0888-0018&client=summon